Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 10-2015 | 09-2015 | 07-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -6,559 | -10,608 | -3,035 | -7,687 |
| Depreciation Amortization | N/A | 560 | 774 | 264 | 506 |
| Accounts receivable | N/A | 205 | 364 | 94 | 219 |
| Other Working Capital | N/A | -580 | 301 | -1,150 | 768 |
| Other Operating Activity | 0 | -171 | 696 | -16 | 855 |
| Operating Cash Flow | $N/A | $-6,545 | $-8,474 | $-3,843 | $-5,339 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -17 | -17 | -17 | N/A |
| Purchase Of Investment | N/A | -5,222 | -15,809 | -4,223 | -12,110 |
| Sale Of Investment | N/A | 9,056 | 15,911 | 3,858 | 12,583 |
| Purchase Sale Intangibles | N/A | N/A | -20 | N/A | -20 |
| Other Investing Activity | 0 | 0 | -20 | 0 | -20 |
| Investing Cash Flow | $N/A | $3,818 | $64 | $-381 | $453 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -100 | -151 | -52 | -103 |
| Financing Cash Flow | $N/A | $-100 | $-151 | $-52 | $-103 |
| Beginning Cash Position | N/A | 7,927 | 11,676 | 7,927 | 11,676 |
| End Cash Position | N/A | 5,099 | 3,116 | 3,651 | 6,688 |
| Net Cash Flow | $N/A | $-2,827 | $-8,560 | $-4,276 | $-4,989 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -6,545 | -8,474 | -3,843 | -5,339 |
| Capital Expenditure | N/A | -17 | -17 | -17 | N/A |
| Free Cash Flow | 0 | -6,562 | -8,490 | -3,860 | -5,339 |